Effects of canagliflozin on Myocardial Infarction: A Post Hoc Analysis of the CANVAS Programme and CREDENCE Trial

Cardiovasc Res 2022;118:1103–14

SGLT2 inhibitor protect against heart failure in diabetic patients, because of this Yu et al. explored the potential impacts of SGLT2i on the clinical features of patients presenting with myocardial infarction, using a post hoc analysis of CANVAS programme and CREDENCE trial.


LinkedIn